Bisphenol A and cardiometabolic risk factors in obese children

Science of the Total Environment

Volumn 470-471, Issue , 2014, Pages 726-732

  Khalil, Naila ^a   Ebert, James R ^b   Wang, Lei ^c   Belcher, Scott ^d   Lee, Miryoung ^e   Czerwinski, Stefan A ^e   Kannan, Kurunthachalam ^c  

^a WRIGHT STATE UNIVERSITY   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Bisphenol A; Childhood obesity; Endocrine disruptor; Non monotonic dose response; Nonalcoholic fatty liver disease; Spline analysis

Indexed keywords

BODY FLUIDS; INSULIN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUTRITION;

BIS-PHENOL A; CHILDHOOD OBESITY; ENDOCRINE DISRUPTOR; NON-ALCOHOLIC FATTY LIVER DISEASE; NON-MONOTONIC DOSE;

PLANTS (BOTANY);

4,4' ISOPROPYLIDENEDIPHENOL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

CHILD HEALTH; ENDOCRINE DISRUPTOR; HEALTH RISK; OBESITY; PHENOL; RISK FACTOR;

AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ETHNICITY; FEMALE; FREE THYROXINE INDEX; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; LIQUID CHROMATOGRAPHY; LIVER DISEASE; LIVER TOXICITY; MALE; MASS SPECTROMETRY; METABOLIC SYNDROME X; OBESITY; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SPLINE ANALYSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; URINE LEVEL;

BISPHENOL A; CHILDHOOD OBESITY; ENDOCRINE DISRUPTOR; NON-MONOTONIC DOSE RESPONSE; NONALCOHOLIC FATTY LIVER DISEASE; SPLINE ANALYSIS;

ANTHROPOMETRY; ASPARTATE AMINOTRANSFERASES; BENZHYDRYL COMPOUNDS; BODY MASS INDEX; CHILD; ENDOCRINE DISRUPTORS; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; OHIO; PHENOLS; RISK FACTORS;

EID: 84886865415     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.09.088     Document Type: Article

References (49)

1. Alonso-Magdalena P., Morimoto S., Ripoll C., Fuentes E., Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 2006, 114:106-112.
2. Alonso-Magdalena P., Ropero A.B., Carrera M.P., Cederroth C.R., Baquie M., Gauthier B.R., et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One 2008, 3:e2069.
3. Alonso-Magdalena P., Vieira E., Soriano S., Menes L., Burks D., Quesada I., et al. Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ Health Perspect 2010, 118:1243-1250.
4. Beausoleil C., Ormsby J.N., Gies A., Hass U., Heindel J.J., Holmer M.L., et al. Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. Chemosphere 2013, (in press). 10.1016/j.chemosphere.2013.06.043.
5. Ben-Jonathan N., Hugo E.R., Brandebourg T.D. Effects of bisphenol A on adipokine release from human adipose tissue: implications for the metabolic syndrome. Mol Cell Endocrinol 2009, 304:49-54.
6. Braun J.M., Kalkbrenner A.E., Calafat A.M., Yolton K., Ye X., Dietrich K.N., et al. Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics 2011, 128:873-882.
7. Cabaton N.J., Wadia P.R., Rubin B.S., Zalko D., Schaeberle C.M., Askenase M.H., et al. Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD-1 mice. Environ Health Perspect 2011, 119:547-552.
8. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., Needham L.L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008, 116:39-44.
9. Carwile J.L., Michels K.B. Urinary bisphenol A and obesity: NHANES 2003-2006. Environ Res 2011, 111:825-830.
10. CDC. Centers for Disease Control and Prevention The Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, September 2013 2013, 16. U.S. Department of Health and Human Services.
11. Chevrier J., Gunier R.B., Bradman A., Holland N.T., Calafat A.M., Eskenazi B., et al. Maternal urinary bisphenol a during pregnancy and maternal and neonatal thyroid function in the CHAMACOS study. Environ Health Perspect 2013, 121:138-144.
12. Desquilbet L., Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 2010, 29:1037-1057.
13. DiVall S.A. The influence of endocrine disruptors on growth and development of children. Curr Opin Endocrinol Diabetes Obes 2013, 20:50-55.
14. Hugo E.R., Brandebourg T.D., Woo J.G., Loftus J., Alexander J.W., Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 2008, 116:1642-1647.
15. Jemal A., Graubard B.I., Devesa S.S., Flegal K.M. The association of blood lead level and cancer mortality among whites in the United States. Environ Health Perspect 2002, 110:325-329.
16. Kandaraki E., Chatzigeorgiou A., Livadas S., Palioura E., Economou F., Koutsilieris M., et al. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab 2011, 96:E480-E484.
17. Kunisue T., Chen Z., Buck Louis G.M., Sundaram R., Hediger M.L., Sun L., et al. Urinary concentrations of benzophenone-type UV filters in U.S. women and their association with endometriosis. Environ Sci Technol 2012, 46:4624-4632.
18. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303-1310.
19. Lohman T.G., Roche AR, Martorell R. Anthropometric standardization reference manual 1988, Human Kinetics, Illinois.
20. Lopez-Espinosa M.J., Fletcher T., Armstrong B., Genser B., Dhatariya K., Mondal D., et al. Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with age of puberty among children living near a chemical plant. Environ Sci Technol 2011, 45:8160-8166.
21. Louet J.F., LeMay C., Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 2004, 6:180-185.
22. Markey C.M., Michaelson C.L., Veson E.C., Sonnenschein C., Soto A.M. The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ Health Perspect 2001, 109:55-60.
23. Marmugi A., Ducheix S., Lasserre F., Polizzi A., Paris A., Priymenko N., et al. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 2012, 55:395-407.
24. Mauvais-Jarvis F. Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab 2011, 22:24-33.
25. Melzer D., Rice N.E., Lewis C., Henley W.E., Galloway T.S. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One 2010, 5:e8673.
26. Melzer D., Osborne N.J., Henley W.E., Cipelli R., Young A., Money C., et al. Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation 2012, 125:1482-1490.
27. Miyawaki J., Sakayama K., Kato H., Yamamoto H., Masuno H. Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. J Atheroscler Thromb 2007, 14:245-252.
28. Moon M.K., Kim M.J., Jung I.K., Koo Y.D., Ann H.Y., Lee K.J., et al. Bisphenol A impairs mitochondrial function in the liver at doses below the no observed adverse effect level. J Korean Med Sci 2012, 27:644-652.
29. Moriyama K., Tagami T., Akamizu T., Usui T., Saijo M., Kanamoto N., et al. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 2002, 87:5185-5190.
30. Newbold R.R., Padilla-Banks E., Jefferson W.N. Environmental estrogens and obesity. Mol Cell Endocrinol 2009, 304:84-89.
31. Ogden C.L., Kuczmarski R.J., Flegal K.M., Mei Z., Guo S., Wei R., et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002, 109:45-60.
32. Ooe H., Taira T., Iguchi-Ariga S.M., Ariga H. Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1. Toxicol Sci 2005, 88:114-126.
33. Polyzos S.A., Kountouras J., Deretzi G., Zavos C., Mantzoros C.S. The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease. Curr Mol Med 2012, 12:68-82.
34. Ronn M., Kullberg J., Karlsson H., Berglund J., Malmberg F., Orberg J., et al. Bisphenol A exposure increases liver fat in juvenile fructose-fed Fischer 344 rats. Toxicology 2013, 303:125-132.
35. Schwimmer J.B., Deutsch R., Kahen T., Lavine J.E., Stanley C., Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006, 118:1388-1393.
36. Shankar A., Teppala S. Urinary bisphenol A and hypertension in a multiethnic sample of US adults. J Environ Public Health 2012, 2012:481641.
37. Shankar A., Teppala S., Sabanayagam C. Bisphenol A and peripheral arterial disease: results from the NHANES. Environ Health Perspect 2012, 120:1297-1300.
38. Shankar A., Teppala S., Sabanayagam C. Urinary bisphenol a levels and measures of obesity: results from the national health and nutrition examination survey 2003-2008. ISRN Endocrinol 2012, 2012:965243.
39. Silver M.K., O'Neill M.S., Sowers M.R., Park S.K. Urinary bisphenol A and type-2 diabetes in U.S. adults: data from NHANES 2003-2008. PLoS One 2011, 6(10):e26868. (ePUB 2011 Oct 26). 10.1371/journal.pone.0026868.
40. Takeuchi T., Tsutsumi O., Nakamura N., Ikezuki Y., Takai Y., Yano T., et al. Gender difference in serum bisphenol A levels may be caused by liver UDP-glucuronosyltransferase activity in rats. Biochem Biophys Res Commun 2004, 325:549-554.
41. Tarantino G., Valentino R., Di Somma C., D'Esposito V., Passaretti F., Pizza G., et al. Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis. Clin Endocrinol (Oxf) 2013, 78:447-453.
42. Trasande L., Attina T.M., Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA 2012, 308:1113-1121.
43. Trasande L., Attina T.M., Blustein J. Bisphenol A and obesity in children and adolescents-reply. JAMA 2013, 309:134-135.
44. Trasande L., Attina T.M., Trachtman H. Bisphenol A exposure is associated with low-grade urinary albumin excretion in children of the United States. Kidney Int 2013, 83(4):741-748. (Epub 2013 Jan 9). 10.1038/ki.2012.422.
45. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 2009, 30:75-95.
46. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.H., et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012, 33:378-455.
47. Wang F., Hua J., Chen M., Xia Y., Zhang Q., Zhao R., et al. High urinary bisphenol A concentrations in workers and possible laboratory abnormalities. Occup Environ Med 2012, 69:679-684.
48. Wang T., Li M., Chen B., Xu M., Xu Y., Huang Y., et al. Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab 2012, 97:E223-E227.
49. Zhang Z., Alomirah H., Cho H.S., Li Y.F., Liao C., Minh T.B., et al. Urinary bisphenol A concentrations and their implications for human exposure in several Asian countries. Environ Sci Technol 2011, 45:7044-7050.